Trial Profile
PhaseI/II study of TS-1+CDDP in combination with Radiotherapy with unresectable and locally advanced for biliary tract cancer.
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Adenocarcinoma; Adenosquamous carcinoma; Bile duct diseases; Biliary cancer; Gallbladder cancer
- Focus Adverse reactions; Therapeutic Use
- 13 Mar 2012 New trial record